Filing Details

Accession Number:
0001237899-14-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-11 16:04:57
Reporting Period:
2014-08-11
Filing Date:
2014-08-11
Accepted Time:
2014-08-11 16:04:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226689 Neil Stahl 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Research And Development S No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-08-11 1,617 $339.33 23,556 No 4 S Direct
Common Stock Disposition 2014-08-11 9,829 $340.04 13,727 No 4 S Direct
Common Stock Disposition 2014-08-11 200 $341.27 13,527 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect by GRAT
Common Stock 10,864 Indirect by GRAT
Common Stock 5,568 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 1,617 shares of Company stock on August 11, 2014 at prices ranging from $339.12 to $339.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2014 at each separate price.
  2. Represents volume-weighted average price of sales of 9,829 shares of Company stock on August 11, 2014 at prices ranging from $340.00 to $340.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2014 at each separate price.
  3. Represents volume-weighted average price of sales of 200 shares of Company stock on August 11, 2014 at prices ranging from $341.04 to $341.28. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2014 at each separate price.